Back to top

Top Ranked Value Stocks to Buy for October 6th

Read MoreHide Full Article

Here are four stocks with buy rank and strong value characteristics for investors to consider today, October 6th:

Pilgrim's Pride Corporation (PPC - Free Report) : This chicken company has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings advancing 11.7% over the last 60 days.

Pilgrim's Pride has a price-to-earnings ratio (P/E) of 11.56, compared with 14.60 for the industry. The company possesses a Value Score of A.

Performance Food Group Company (PFGC - Free Report) : This distributor of food and food-related products has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings increasing 0.7% over the last 60 days.

Performance Food Group has a price-to-earnings ratio (P/E) of 19.86, compared with 21.70 for the industry. The company possesses a Value Score of A.

AeroCentury Corp. (ACY - Free Report) : This acquirer of aircraft and aircraft engines has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings advancing 9.9% over the last 60 days.

AeroCentury has a price-to-earnings ratio (P/E) of 8.11, compared with 12.80 for the industry. The company possesses a Value Score of A.

Owens Corning (OC - Free Report) : This seller of glass fiber reinforcements has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings increasing 0.2% over the last 60 days.

Owens Corning has a price-to-earnings ratio (P/E) of 18.43, compared with 19.90 for the industry. The company possesses a Value Score of A.

See the full list of top ranked stocks here

Learn more about the Value score and how it is calculated here.

5 Trades Could Profit "Big-League" from Trump Policies

If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.

Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure.

See these buy recommendations now >>



More from Zacks Zacks #1 Rank Additions

You May Like